Subthemes arising under this theme were: general cancer risks and management options (7/19, 36.8%), cancer risks based on family history/ancestry (4/19, 21.1%), insurance (4/19, 21.1%), other genes beyond BRCA1/BRCA2/PALB2 (3/19, 15.8%) and variants of uncertain significance (1/19, 5.3%). This evidence concerns the gene PALB2 and cancer.